Li, Z., Qian, J., Li, J., & Zhu, C. (2019). Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway. Exp Ther Med.
শিকাগো স্টাইলে সাইটেশনLi, Zhixiang, Jun Qian, Jing Li, এবং Chao Zhu. "Knockdown of LncRNA-HOTAIR Downregulates the Drug-resistance of Breast Cancer Cells to Doxorubicin Via the PI3K/AKT/mTOR Signaling Pathway." Exp Ther Med 2019.
এমএলএ সাইটেশনLi, Zhixiang, Jun Qian, Jing Li, এবং Chao Zhu. "Knockdown of LncRNA-HOTAIR Downregulates the Drug-resistance of Breast Cancer Cells to Doxorubicin Via the PI3K/AKT/mTOR Signaling Pathway." Exp Ther Med 2019.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.